Bayzed Health Group (HKG:2609) raised HK$467.8 million in net proceeds from its initial public offering in Hong Kong, according to a Friday after-market filing with the Hong Kong bourse.
The oncology-focused healthcare services provider offered 133,105,800 shares priced at HK$4.22 apiece, the lower end of the indicative price range of as high as HK$6.75.
The public offering of the deal was 25.92 times subscribed, resulting in a total of 16,238,400 shares offered under this component, following the reallocation of 2,927,400 shares from the international offering.
The international offering was 0.98 time subscribed, and the number of shares offered was reduced to 116,867,400 following the reallocation.
Bayzed Health will make its trading debut on the Hong Kong Stock Exchange on Monday, June 23, when the opening bell sounds at 9am.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。